GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Pharmalabs Ltd (BOM:543748) » Definitions » Additional Paid-In Capital

Aarti Pharmalabs (BOM:543748) Additional Paid-In Capital : ₹0 Mil(As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Aarti Pharmalabs Additional Paid-In Capital?


Aarti Pharmalabs's quarterly additional paid-in capital declined from Mar. 2024 (₹4,406 Mil) to Jun. 2024 (₹0 Mil) but then stayed the same from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹0 Mil).

Aarti Pharmalabs's annual additional paid-in capital increased from Mar. 2022 (₹4,403 Mil) to Mar. 2023 (₹4,406 Mil) but then stayed the same from Mar. 2023 (₹4,406 Mil) to Mar. 2024 (₹4,406 Mil).


Aarti Pharmalabs Additional Paid-In Capital Historical Data

The historical data trend for Aarti Pharmalabs's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Pharmalabs Additional Paid-In Capital Chart

Aarti Pharmalabs Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Additional Paid-In Capital
- 4,403.25 4,405.75 4,405.75

Aarti Pharmalabs Quarterly Data
Mar21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 4,405.75 - -

Aarti Pharmalabs Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Aarti Pharmalabs Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Aarti Pharmalabs's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarti Pharmalabs Business Description

Traded in Other Exchanges
Address
Mulund Goregaon Link Road, 2nd floor, 204, Udyog Kshetra, Mulund West, Mumbai, MH, IND, 400080
Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. It manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, and xanthine derivatives in India. It also offers Contract Development and Manufacturing Services (CDMS) for drug substance (NCE, RSM, Intermediates) projects. Geographically, the company generates maximum revenue from its customers located outside India.

Aarti Pharmalabs Headlines

No Headlines